- NHL Treatment
- Hodgkin's Treatment
- Clinical Trials
- Monoclonal Antibodies
- Types of NHL
Lymphoma and Pets
LLS Launches Co-Pay Assistance Fund for Mantle Cell Lymphoma
The Leukemia and Lymphoma Society, the largest charity in the world dedicated to blood disorders, has announced a new co-pay assistance program fund.
The Leukemia and Lymphoma Society's Co-Pay Assistance Program provides direct financial assistance to patients living with a blood cancer to help them pay for insurance premiums and co-pay obligations.
A new assistance program
The latest disease Co-Pay Assistance Program fund at the LLS has been established for qualified patients who have been diagnosed with mantle cell lymphoma (MCL).
The MCL co-pay program is available for patients who have health insurance, including Medicare and Medicaid, and who meet specific financial criteria.
Approved MCL patients might receive as much as $5,000 per year. Acceptance is provided on a first-come, first-served basis. It remains open for as long as funding is available.
Patients can apply for the program by calling toll-free (877) 557-2672 or by going online to www.lls.org/copay.